LDLR and Hypercholesterolemia: To investigate the predictive validity of the PBMC LDLR-H3K27ac epigenetic-transcriptional effect for fetal-originated hypercholesterolemia predisposition, we conducted validation using plasma samples from antenatal dexamethasone-exposed neonates and non-exposed controls.